More

    COVID-19

    spot_img

    World’s 1st intra nasal vaccine iNCOVACC by Bharat Biotech approved for emergency use

    Bharat Biotech's intra nasal vaccine iNCOVACC (BBV154), has received approval under Restricted Use in Emergency Situation for ages 18 and above in India. This is World's First Intranasal Vaccines to receive approvals for Primary 2 dose schedule . Highlights of Bharat Biotech Intra Nasal Vaccine - iNCOVACC iNCOVACC receives approval under Restricted Use in Emergency Situations for ages 18 and above.Bharat Biotech is a global leader in...

    Moderna sues Pfizer and BioNTech for violating the Covid19 vaccine patent

    On Friday, mRNA vaccine developer Moderna filed a patent infringement lawsuit against Pfizer and its German partner BioNTech over the development of the first COVID-19 vaccine approved in the United States, claiming that the defendants stole technology that Moderna had developed years before the pandemic. Moderna in a tweet wrote, Moderna is filing the suit against Pfizer and BioNTech, alleging infringement of patents central to Moderna’s...

    Covid-19 ‘Tragic Milestone’ in 2022 demands for more immunisation – Tedros

    The world has recorded a 'Tragic Milestone' of 1 Million Covid-19 deaths in 2022. According to World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus. This "tragic milestone" calls for increased vaccination to combat the virus. “We cannot say we are learning to live with COVID-19 when one million people have died with COVID-19 this year alone, when we are two-and-a-half years into the...

    Intranasal Covid vaccine BBV154 is safe, regulators approvals awaited: Bharat Biotech

    In controlled clinical trials for the Covid vaccine BBV154 as a primary and as a heterologous booster, Bharat Biotech International Limited (BBIL) said today, its intranasal Covid-19 vaccine BBV154 has demonstrated to be safe, well-tolerated, and immunogenic in subjects. BBIL has submitted the data from both the Phase III trials for approval to India's regulatory authorities. BBV154 is a recombinant replication-deficient adenovirus vectored vaccine with...

    Japan Approves COVAXIN booster dose for Travelers; reinforces the effectiveness of Universal Covid Vaccine

    Japan on Friday accorded approval for Bharat Biotech's Covaxin booster dose for travellers. In April this year, the nation included the Made-in-India Covid-19 vaccine in the list of recognised vaccines. And, now (August 5), Japan has also approved the booster shot of Covaxin. Bharat Biotech wrote in a statement, "We are proud to announce, Japan has approved COVAXIN booster dose for travellers". Earlier this month, the...

    New Peer Review Proves COVAXIN Booster Dose Provides Multiple Benefits

    According to a new peer-reviewed study, administration of Bharat Biotech's COVAXIN Booster (3rd dose), after 6 months of two dose vaccination, dramatically increased neutralizing antibody responses against both homologous and heterologous strains (Alpha, Beta, Delta, Delta Plus and Omicron) and showed increased memory B cell response. According to the latest peer review study published in Nature, COVAXIN, its whole-virion inactivated COVID-19 vaccine, has proven to...

    COVAXIN is Safe, Highly Immunogenic in 2-18 Years Old – The Lancet Review

    Bharat Biotech today announced COVAXIN Latest Peer Review published in the Lancet Infectious Disease Journal . The company stated, the peer review of BBV152 (COVAXIN), its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study. The study has been accepted and published in Lancet Infectious diseases, peer reviewed high impact factor journal....

    COVAXIN booster can defend new variants of concern: ICMR Study

    A COVAXIN booster dose has protective efficacy against the Delta variant and the Omicron sub-variants BA.1.1 and BA.2, according to a recent published study by the Indian Council of Medical Research (ICMR), the National Institute of Virology (NIV), and Bharat Biotech. The neutralising antibody response against variants of concern, such as Delta and Omicron, was found to be enhanced by the booster dosage of Covaxin....

    Mumbai Covid cases on the rise again, City on Alert

    Mumbai Covid cases is witnessing increase in Covid19 once again. Officials are gearing up to increase the Tests for Covid in the city. The positivity rate has risen to 6%, according to the civic body Brihanmumbai Municipal Corporation, or BMC. It has asked officials to increase testing "on a war footing" right away. It has also been urged that testing labs be proactive and...

    North Korea hit by a killer new fever, Covid19, Emergency Declared

    North Korea reported on Friday that six people who were ill with above normal body temperature have passed away, with one of them testing positive for Covid-19, the official Korean Central News Agency reported as per news agency AFP. "A fever whose cause couldn't be identified explosively spread nationwide from late April… Six persons died (one of them tested positive for the BA.2 sub-variant of...

    Latest Updates